Ukuphindaphinda - inaliti ye-evolocumab yecholesterol

Umxholo

• Ixabiso
• Yenzelwe ntoni
• Kusetyenziswa kwanjani
• Iziphumo ebezingalindelekanga ezinokwenzeka
• Ezirhabaxa Izimo

I-Repatha liyeza elitofwayo eliqukethe ukwakheka kwe-evolocumab, into esebenza esibindini inceda ukunciphisa amanqanaba e-cholesterol egazini.

Eli yeza liveliswa ziilabhoratri zeAmgen ngohlobo lwesirinji esele igcwalisiwe, efana neepeni ze-insulin, ezinokuhanjiswa ekhaya emva kokuyalelwa ngugqirha okanye ngumongikazi.

Ixabiso

I-Repatha, okanye i-evolocumab, inokuthengwa kwiikhemesti ezibonisa amayeza kwaye ixabiso lawo lingahluka phakathi kwe-1400 reais, kwisirinji esele igcwalisiwe eyi-140 mg, ukuya kuma-2400 reais, kwiisirinji ezi-2.

Yenzelwe ntoni

Ukuphinda kuboniswe kunyango lwezigulana ezinamanqanaba aphezulu egazi cholesterol ebangelwa yi-hypercholesterolemia yokuqala okanye i-hypercholesterolemia, kwaye kufuneka ihlale ihamba nokutya okunezondlo.

Kusetyenziswa kwanjani

Indlela yokusebenzisa iRepatha, evolocumab, inenaliti ye-140 mg rhoqo kwiiveki ezi-2 okanye inaliti enye ye-420 mg kanye ngenyanga. Nangona kunjalo, idosi inokuhlengahlengiswa ngugqirha ngokwembali yonyango.

Iziphumo ebezingalindelekanga ezinokwenzeka

Iziphumo eziphambili zeRepatha zibandakanya urticaria, ubomvu kunye nokurhawuzelela ulusu, ubunzima bokuphefumla, ukuphuma kwempumlo, umqala obuhlungu okanye ukudumba kobuso, umzekelo. Ukongeza, i-Repatha inokubangela ukuba uxabane nendawo yenaliti.

Ezirhabaxa Izimo

Ukuphindaphinda kuyaphikiswa kwizigulana ezine-hypersensitivity to evolocumab okanye naliphi na elinye ifomula.

Jonga neengcebiso zesondlo malunga nokutya okunciphisa i-cholesterol: